Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Neoplasms by Site × Tumor-Agnostic × Clear all

Phase

Phase 2 1 Phase 1/2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 11 Genitourinary 7 Gastrointestinal 7 Gynecologic 5 CNS 4 Head & Neck 3 Dermatologic 3 Tumor-Agnostic 1 Sarcoma 1 Plasma cell 1 Other hematologic neoplasm 1 Lymphoid 1 Breast 1

Conditions

Neoplasms 881 Neoplasm Metastasis 265 Carcinoma 34 Adenocarcinoma 18 Carcinoma, Squamous Cell 10 Neoplasms by Site 1 Neoplasms by Histologic Type 1 Neoplasm, Residual 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01629758 2015-03-06

Safety Study of IL-21/Anti-PD-1 Combination in the Treatment of Solid Tumors

Bristol-Myers Squibb

Phase 1 Completed

Neoplasms by Site

Data powered by HemOnc (CC BY 4.0) Colophon ⚡